Document Detail


The German registry for nephrogenic systemic fibrosis: findings from 23 patients.
MedLine Citation:
PMID:  20497754     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND AIM: Nephrogenic systemic fibrosis (NSF) is a highly debilitating disorder primarily affecting the skin, but also other organ compartments. So far, it has only occurred in patients suffering from acute or chronic renal failure, with almost all of them having been exposed to gadolinium-based contrast agents (GBCA). The NSF registry was initiated on behalf of the German Society of Nephrology. The aim was to analyze the development, risk factors and clinical course of patients suffering from NSF. PATIENTS AND METHODS: Between July 2007 and July 2009, 23 patients were registered (12/23 (52,2%) male and 11/23 (47,8%) female). Onset of NSF symptoms was between 2002 and 2008, with a maximum of 8 cases in 2005. Since January 2008 no patient with a new onset of NSF has been reported. On all patients nuclear magnetic resonance procedures were performed between 1 day and 3 years (median 30 days) before the onset of symptoms ("index procedure"). At the time of the index procedure 21/23 (91,3%) patients required dialysis, 15/22 patients (68,2%) showed signs and symptoms of atherosclerosis and 17/20 (76,5%) of inflammation. 22/23 patients remained in chronic kidney disease stage 5D. Upper and lower extremities were affected in 18/23 (78,3%) patients; 20/23 (87%) developed joint contractures. RESULTS: Our data confirm previous observations that NSF is associated with impaired renal function and the application of GBCA. In individual cases the interval between the index procedure and the onset of symptoms lasted years. CONCLUSION: The incidence of NSF has decreased rapidly within the past 4 years. This could be due to general awareness within the medical community and the application of macrocyclic chelates.
Authors:
S Becker; S Walter; O Witzke; B Wilde; U Hillen; D Napieralski; A Kreuter; P Altmeyer; G Schieren; A Daul; L-C Rump; A Kribben
Related Documents :
16202784 - The survival advantage of patients with cystic fibrosis diagnosed through neonatal scre...
12693794 - Exhaled nitric oxide in cystic fibrosis patients with allergic bronchopulmonary aspergi...
15041034 - Acetylcholine mediated vasodilatation in the microcirculation of patients with chronic ...
17969494 - Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent.
12939004 - The toronto outcome measure for craniofacial prosthetics: a condition-specific quality-...
24359274 - A longitudinal study on nodding syndrome-a new african epilepsy disorder.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical nephrology     Volume:  73     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-25     Completed Date:  2010-08-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  426-30     Citation Subset:  IM    
Affiliation:
Department of Nephrology, University Duisburg-Essen, Essen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Contrast Media / adverse effects
Female
Gadolinium / adverse effects
Germany / epidemiology
Humans
Kidney Diseases / complications
Male
Middle Aged
Nephrogenic Fibrosing Dermopathy / epidemiology*,  etiology
Registries
Risk Factors
Chemical
Reg. No./Substance:
0/Contrast Media; 7440-54-2/Gadolinium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Homocysteine and folic acid levels in hemodialysis patients treated with sevelamer hydrochloride.
Next Document:  The effect of etanercept on suppression of the systemic inflammatory response in chronic hemodialysi...